VYNE Therapeutics
VYNE
VYNE
55 hedge funds and large institutions have $63M invested in VYNE Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
42% less capital invested
Capital invested by funds: $110M → $63M (-$46.5M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
55
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.15M | |
| 2 | +$225K | |
| 3 | +$154K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$144K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$114K |
Top Sellers
| 1 | -$24M | |
| 2 | -$442K | |
| 3 | -$388K | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$367K |
| 5 |
JPMorgan Chase & Co
New York
|
-$317K |